Literature DB >> 15315338

Expression of costimulatory molecules B7/CD28 in systemic lupus erythematosus.

Shaoxian Hu1, Deding Tao, Peigen He.   

Abstract

The expression of the costimulatory molecules B7/CD28 in peripheral blood mononuclear cells (PBMC) of the patients with systemic lupus erythematosus (SLE) and its relation to the pathogenesis of SLE were studied. The expression of the costimulatory molecules in PBMC in 30 patients with active SLE and 20 cases of healthy controls was detected by using the techniques of immunofluorescence and flow cytometer. The result showed that the expression percentage of CD28+, CD4+ CD28+ in T cells of PBMC from the patients with SLE decreased significantly as compared with that in healthy control group, while the expression percentage of CD80+, CD19+ CD80+ in B cells was significantly increased than that in healthy control group (P<0.01). It suggested that the abnormal expression of costimulatory molecules B7/CD28 played a role in the pathogenesis of SLE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15315338     DOI: 10.1007/bf02832002

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  9 in total

Review 1.  Co-stimulation in T cell responses.

Authors:  C A Chambers; J P Allison
Journal:  Curr Opin Immunol       Date:  1997-06       Impact factor: 7.486

Review 2.  Immunosuppression through blockade of CD28:B7-mediated costimulatory signals.

Authors:  T A Judge; A Tang; L A Turka
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients.

Authors:  D Folzenlogen; M F Hofer; D Y Leung; J H Freed; M K Newell
Journal:  Clin Immunol Immunopathol       Date:  1997-06

5.  Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1)

Authors:  B J Chambers; M Salcedo; H G Ljunggren
Journal:  Immunity       Date:  1996-10       Impact factor: 31.745

6.  Decreased T cell response to anti-CD2 in systemic lupus erythematosus and reversal by anti-CD28: evidence for impaired T cell-accessory cell interaction.

Authors:  D A Horwitz; F L Tang; M M Stimmler; A Oki; J D Gray
Journal:  Arthritis Rheum       Date:  1997-05

7.  Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis.

Authors:  H Kaneko; K Saito; H Hashimoto; H Yagita; K Okumura; M Azuma
Journal:  Clin Exp Immunol       Date:  1996-11       Impact factor: 4.330

Review 8.  Epitope spreading: the role of self peptides and autoantigen processing by B lymphocytes.

Authors:  M J Mamula
Journal:  Immunol Rev       Date:  1998-08       Impact factor: 12.988

Review 9.  The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells.

Authors:  A J McAdam; A N Schweitzer; A H Sharpe
Journal:  Immunol Rev       Date:  1998-10       Impact factor: 12.988

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.